Kathryn Bowsher Email & Phone Number

San Francisco, Ca, Us

As Managing Director, I provide strategic commercial consultation with a focus on scaling innovations in health. For 15+ years, I have served as a trusted commercial strategist and transformed GTM, user adoption and engagement models, and delivery solutions for a diverse clientele ranging from new digital health ventures to Fortune 100 biopharma. Areas of Strength: + Reframing Problems & Value Proposition+ Navigating Compliance Hurdles + Facilitating Multi-Stakeholder Adoption+ Overcoming Complex Roadblocks+ Bringing Novel Digital Health Solutions to the Market+ Forging Non-Traditional Partnerships+ Inspiring and Empowering Teams to Push Beyond Traditional Boundaries to Drive Transformative Change+ Working Together to Find New Possibilities within Unchartered Territory Select Engagement Highlights: + Addressed growing systemic challenges posed by a changing market for a Top 10 Biopharma by introducing a new compliant sales tool framework that enabled a 300+-person Field Force to successfully market a novel digital health solution that provides “right patient, right drug, right time” capabilities to customers.+ This framework was deemed highly successful, adopted across the entire oncology division, and written-up as a Patient Centricity Success story in the company’s 2018 annual report. + Garnered investor attention by reframing value proposition for a cloud-based provider that provides secure access to health data. + Repositioned US GTM for a Danish AI company focused on the X-ray market and looking to expand into the U.S. market. Conducted market research and uncovered need for a different application and positioning.+ Reframed focus for a Fortune 500 Biopharma’s leading-edge Pill+ digital initiatives, providing advisory that identified and addressed culture, governance, and strategic alignment issues deeply impacting company’s ability to gain forward momentum.

Nassau Street Ventures is a community of investors and entrepreneurs passionate about innovation.

Menlo Park, California, Us

NephroSant's diagnostic tests use AI to identify kidney health and transplant rejection from urine samples before symptoms. DigitalDx invests in game-changing, AI powered tools that empower doctors to diagnose patient illnesses earlier, more accurately, and less invasively.

Bethesda, Md, Us

In 2019, I cofounded Pocket Naloxone Corp., which tackles access barriers by taking novel OTC opioid overdose rescue product to the retail market. Chair of the Board 2021 – 2023, Board Director, 2019 – 2023

Navigating healthcare, Managing team, Love, Presence

Greater Philadelphia, Pa, Us

Red Team Associates provides commercial direction that helps clients succeed in a world of new healthcare realities.

In 2010, I was brought in by investors to turnaround a startup provider of novel antimicrobial textiles struggling with regulatory and GTM challenges. I positioned the company and self as a thought leader for innovative horizontal approaches to infection prevention, generating coverage in Becker’s Hospital Review and CBS News, among others and reworked the business plan, successfully raising a $3M over-subscribed, up-round despite challenging market of 2011.

From 1999 to 2010, I provided GTM strategy and commercial development consultation for healthcare companies and investors. Select Client Highlights: + Served as commercial lead for an ultra-orphan drug indicated for Nephropathic Cystinosis from late pre-clinical up to start of phase 3. Client raised stock guidance based on early success with the drug. + Developed indication strategy and early positioning for an oncology biotech that sold to Sanofi for $500M after first phase 2 results.+ Created business plan for IMS Health (IQVIA) to drive revenue growth by expanding customer base served by existing data assets.+ Drove market development for the west coast and emerging biopharma segments for a leading healthcare market research firm, resulting in 4 new key account relationships and an expanded positioning for future growth.

In 1998, I was recruited to head marketing for a provider of minimally invasive treatments for snoring, sleep apnea, and other disorders, where I led a team of 4 direct reports as an officer of a public company. Within short time, grew sales by 70% and launched an Obstructive Sleep Apnea application, with disposable achieving 163% of budget. Contributing to this success was the launch of a DTC promotion program (including both traditional media and web) generating 2,500 patient responses in 1 week.

Deerfield, Illinois, Us

While at Baxter International, a Global Fortune 500 Biopharma, I specialized in new products to treat renal failure, and advanced rapidly with 3 promotions in 6 years, including a double bump for the third promotion. As a Commercial Leader, I was responsible for everything from allocation of feasibility dollars through marketing of mature products; led multiple cross-functional R&D teams; and managed internal medical and R&D interface with European marketing group and Scientific Advisory Board. I was also a member of the Health Economics and EU Price Harmonization task forces.Leadership roles held during this time included: Director, Global Marketing, Peritoneal Dialysis (PD) Solutions, Renal Division Senior Marketing Manager, European New Products Assistant Business Unit Director, Renal France Marketing Manager, Global Marketing, PD Solutions

New York, New York, Us

While at Goldman, Sachs & Co, I built the firm’s position as leading underwriter of government asset sale securities within an intensely competitive marketplace and recommended a first of its kind structure that won Goldman the lead manager role for a significant bond issue in a new market.

Mba

Ab

Education record